HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
KCLB Cat# 10023, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
KCLB |
10023 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
2026-09-12 05:40:20 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
CCLV Cat# CCLV-RIE 0141, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
CCLV |
CCLV-RIE 0141 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
2026-09-12 05:40:20 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
BCRC Cat# 60042, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
BCRC |
60042 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
2026-09-12 05:40:20 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
BCRJ Cat# 0101, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
BCRJ |
0101 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
2026-09-12 05:40:20 |
2898 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated Discontinued
|
CCTCC Cat# GDC0004, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
CCTCC |
GDC0004 |
BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
2026-09-12 05:40:20 |
2898 |
IGROV-1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1304
|
Homo sapiens (Human)
|
Ovarian endometrioid adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050 PMID:3335022 PMID:8564971 PMID:9331090 PMID:9443634 PMID:9488600 PMID:9636834 PMID:10700174 PMID:10817511 PMID:12960427 PMID:15748285 PMID:16319398 PMID:17088437 PMID:19372543 PMID:20164919 PMID:22068913 PMID:22328975 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:22710073 PMID:23415752 PMID:23839242 PMID:23856246 PMID:23913215 PMID:23933261 PMID:24023729 PMID:24279929 PMID:24670534 PMID:25230021 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27235858 PMID:27377824 PMID:27397505 PMID:27561551 PMID:27807467 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31733513 PMID:31978347 PMID:32612269 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Female |
Igrov-1, IGROV 1, IGR-OV1, IGROV1, Igrov1, IGR.OV1, IGROV, OV1/P, OV1/p, OV1-P |
|
|
BTO:BTO_0002575, CLO:CLO_0006672, EFO:EFO_0005385, CLDB:cl2627, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:897, BioSample:SAMN03470926, BioSample:SAMN10988218, cancercelllines:CVCL_1304, Cell_Model_Passport:SIDM00151, ChEMBL-Cells:CHEMBL3307502, ChEMBL-Targets:CHEMBL613984, CLS:305556, Cosmic:688100, Cosmic:875857, Cosmic:897430, Cosmic:905968, Cosmic:920360, Cosmic:947357, Cosmic:1044236, Cosmic:1092607, Cosmic:1093557, Cosmic:1102823, Cosmic:1175880, Cosmic:1305334, Cosmic:1312353, Cosmic:1707557, Cosmic:1709252, Cosmic:1998449, Cosmic:2464669, Cosmic-CLP:905968, DepMap:ACH-000966, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:905968, GEO:GSE23440, GEO:GSE25191, GEO:GSM2127, GEO:GSM50218, GEO:GSM50281, GEO:GSM313715, GEO:GSM711720, GEO:GSM743472, GEO:GSM743496, GEO:GSM750827, GEO:GSM799361, GEO:GSM799424, GEO:GSM844567, GEO:GSM844568, GEO:GSM844569, GEO:GSM844570, GEO:GSM846360, GEO:GSM851919, GEO:GSM887160, GEO:GSM888232, GEO:GSM1153432, GEO:GSM1181284, GEO:GSM1181285, GEO:GSM1291142, GEO:GSM1374571, GEO:GSM1669930, GEO:GSM2124667, IARC_TP53:21072, IARC_TP53:21125, IARC_TP53:30209, LiGeA:CCLE_165, Lonza:175, Millipore:SCC203, NCI-DTP:IGR-OV1, PharmacoDB:IGROV1_654_2019, PRIDE:PXD003539, PRIDE:PXD003668, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_1304, PubChem_Cell_line:CVCL_1304, SKY/M-FISH/CGH:2739, Wikidata:Q54897382 |
|
|
CVCL_1304 |
2026-09-12 05:45:55 |
32 |
IGR-37
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2075
|
Homo sapiens (Human)
|
Melanoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:405430 PMID:2337917 PMID:2344628 PMID:6539703 PMID:6929009 PMID:10709110 PMID:11668190 PMID:21584902 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
IgR-37, IGR 37, IGR37, MM1, Institut Gustave Roussy-37 |
|
|
BTO:BTO_0005747, CLO:CLO_0006670, EFO:EFO_0006597, CLDB:cl2625, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03472906, BioSample:SAMN10988387, cancercelllines:CVCL_2075, Cell_Model_Passport:SIDM01066, ChEMBL-Cells:CHEMBL3308435, ChEMBL-Targets:CHEMBL613985, Cosmic:888064, Cosmic:1995453, Cosmic-CLP:1240153, DepMap:ACH-000650, DSMZ:ACC-237, DSMZCellDive:ACC-237, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240153, GEO:GSM557941, GEO:GSM887158, GEO:GSM888230, GEO:GSM1669928, IARC_TP53:28327, LiGeA:CCLE_202, LINCS_LDP:LCL-1248, PharmacoDB:IGR37_652_2019, PRIDE:PXD030304, Progenetix:CVCL_2075, PubChem_Cell_line:CVCL_2075, Wikidata:Q54897367 |
|
|
CVCL_2075 |
2026-09-12 05:45:55 |
6 |
IM95m
Resource Report
Resource Website
Discontinued
|
JCRB Cat# NIHS0334, RRID:CVCL_2962
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Characteristics: Compared to the parent cell line, it produces higher level of HGF, IL8 and VEGFA., Population: Japanese., Part of: MD Anderson Cell Lines Project.
|
PMID:14609362 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28196595 PMID:29435981
|
Cancer cell line
|
Male |
IM95M, IM95 m, IM-95m |
JCRB |
NIHS0334 |
CLO:CLO_0037141, EFO:EFO_0006598, ArrayExpress:E-MTAB-2706, BioSample:SAMN03473261, Cosmic:2484953, Cosmic:2807628, EGA:EGAS00001000610, FANTOM5_SSTAR:10796-110I4, GEO:GSM844572, GEO:GSM1374574, JCRB:JCRB1075.1, JCRB:NIHS0334, LINCS_LDP:LCL-1534, PharmacoDB:IM95m_658_2019, Wikidata:Q54897512 |
cvcl_2961 |
|
CVCL_2962 |
2026-09-12 05:45:59 |
0 |
IM95
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_2961
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:14609362 PMID:20215515 PMID:22460905 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
Im95, IM-95 |
|
|
BTO:BTO_0005908, CLO:CLO_0037140, EFO:EFO_0006446, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:900, BioSample:SAMN03470904, BioSample:SAMN10988365, cancercelllines:CVCL_2961, Cell_Model_Passport:SIDM00602, ChEMBL-Cells:CHEMBL4295463, ChEMBL-Targets:CHEMBL4296441, Cosmic:1187278, Cosmic:1482079, Cosmic:1995455, Cosmic:2443798, Cosmic-CLP:1240155, DepMap:ACH-000919, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:1240155, GEO:GSM552360, GEO:GSM562403, GEO:GSM827403, GEO:GSM844571, GEO:GSM887161, GEO:GSM888233, GEO:GSM1237675, GEO:GSM1237700, GEO:GSM1374573, GEO:GSM1669933, IARC_TP53:30079, JCRB:JCRB1075.0, JCRB:NIHS0333, LiGeA:CCLE_708, LINCS_LDP:LCL-1884, PharmacoDB:IM95_657_2019, PRIDE:PXD030304, Progenetix:CVCL_2961, PubChem_Cell_line:CVCL_2961, Wikidata:Q54897510 |
|
|
CVCL_2961 |
2026-09-12 05:45:59 |
7 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
JCRB Cat# IFO50283, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
JCRB |
IFO50283 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
|
|
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
CCTCC Cat# GDC0107, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
CCTCC |
GDC0107 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
DSMZ Cat# ACC-165, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
DSMZ |
ACC-165 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
Coriell Cat# GM03320, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
Coriell |
GM03320 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Possibly Discontinued Discontinued
|
Coriell Cat# AG03320, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
Coriell |
AG03320 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
ATCC Cat# CCL-127, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
ATCC |
CCL-127 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
KCLB Cat# 10127, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
KCLB |
10127 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 05:46:01 |
353 |
J82
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0359
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian; Swedish., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:77569 PMID:571047 PMID:687519 PMID:833871 PMID:864752 PMID:870558 PMID:2594029 PMID:3413074 PMID:3518877 PMID:3708594 PMID:4057431 PMID:6220172 PMID:6244232 PMID:6582512 PMID:6823318 PMID:7787250 PMID:8077054 PMID:9137463 PMID:9850064 PMID:11416159 PMID:11921286 PMID:12127398 PMID:14762065 PMID:15846775 PMID:16885334 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23401075 PMID:24035680 PMID:24367658 PMID:25997541 PMID:26589293 PMID:27270441 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
J-82, J 82, J82COT, J82 COT, J82 CO'T, J82/WT |
|
|
BTO:BTO_0001671, CLO:CLO_0007006, EFO:EFO_0002210, MCCL:MCC:0000253, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-1, BioSample:SAMN03471085, BioSample:SAMN10987788, cancercelllines:CVCL_0359, CCRID:1101HUM-PUMC000346, CCRID:3101HUMTCHu218, CCRID:4201HUM-CCTCC00225, CCTCC:GDC0225, Cell_Model_Passport:SIDM00693, ChEMBL-Cells:CHEMBL3308508, ChEMBL-Targets:CHEMBL614586, CLS:305055, Cosmic:753566, Cosmic:755399, Cosmic:760474, Cosmic:808517, Cosmic:809378, Cosmic:845571, Cosmic:846276, Cosmic:867838, Cosmic:943731, Cosmic:1016887, Cosmic:1046674, Cosmic:1093984, Cosmic:1175827, Cosmic:1285119, Cosmic:1285996, Cosmic:1302362, Cosmic:1927308, Cosmic:1995459, Cosmic:2050445, Cosmic:2057450, Cosmic:2444229, Cosmic:2686097, Cosmic:2700997, Cosmic-CLP:753566, DepMap:ACH-000396, EGA:EGAS00001000978, GDSC:753566, GEO:GSM136231, GEO:GSM492491, GEO:GSM827204, GEO:GSM887167, GEO:GSM888239, GEO:GSM1374575, GEO:GSM1574579, GEO:GSM1669946, IARC_TP53:3721, IARC_TP53:21416, IGRhCellID:J82, KCB:KCB 2014052YJ, KCLB:30001, LiGeA:CCLE_551, LINCS_LDP:LCL-1714, PharmacoDB:J82_675_2019, PRIDE:PXD030304, PRIDE:PXD032049, Progenetix:CVCL_0359, PubChem_Cell_line:CVCL_0359, Wikidata:Q54898490 |
|
|
CVCL_0359 |
2026-09-12 05:46:19 |
38 |
HT-1376
Resource Report
Resource Website
10+ mentions
Discontinued
|
RRID:CVCL_1292
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:191628 PMID:3518877 PMID:3708594 PMID:6244232 PMID:7787250 PMID:8873383 PMID:9850064 PMID:11416159 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23401075 PMID:24035680 PMID:24367658 PMID:24459064 PMID:25997541 PMID:26055179 PMID:26589293 PMID:27270441 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
HT1376, HT 1376, HT 1376.T |
|
|
BTO:BTO_0003461, CLO:CLO_0004268, CLO:CLO_0004279, EFO:EFO_0002203, CLDB:cl1743, CLDB:cl1744, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1472, ATCC:CRL-7927, BCRC:60058, BioGRID_ORCS_Cell_line:414, BioSample:SAMN01821564, BioSample:SAMN01821635, BioSample:SAMN03472820, BioSample:SAMN10988225, cancercelllines:CVCL_1292, Cell_Model_Passport:SIDM00678, ChEMBL-Cells:CHEMBL3308398, ChEMBL-Cells:CHEMBL3308610, ChEMBL-Targets:CHEMBL612258, ChEMBL-Targets:CHEMBL614664, CLS:305100, Cosmic:715761, Cosmic:760481, Cosmic:845562, Cosmic:907066, Cosmic:925821, Cosmic:928815, Cosmic:943733, Cosmic:1046691, Cosmic:1285118, Cosmic:1285987, Cosmic:1927303, Cosmic:2050444, Cosmic:2057449, Cosmic:2444252, Cosmic:2686096, Cosmic-CLP:907066, DepMap:ACH-000724, DSMZ:ACC-397, DSMZCellDive:ACC-397, ECACC:87032402, EGA:EGAS00001000978, ENCODE:ENCBS266UUE, ENCODE:ENCBS956LPK, GDSC:907066, GEO:GSM136230, GEO:GSM142305, GEO:GSM142310, GEO:GSM827432, GEO:GSM887139, GEO:GSM888210, GEO:GSM1374560, GEO:GSM1574553, GEO:GSM1669911, IARC_TP53:3720, IGRhCellID:HT1376, IZSLER:BS TCL 70, KCLB:21472, LiGeA:CCLE_036, LINCS_LDP:LCL-1712, PharmacoDB:HT1376_628_2019, PRIDE:PXD030304, Progenetix:CVCL_1292, PubChem_Cell_line:CVCL_1292, Wikidata:Q54896503 |
|
|
CVCL_1292 |
2026-09-12 05:45:30 |
12 |
HT
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1290
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2313723 PMID:19278952 PMID:19358282 PMID:20164919 PMID:20215515 PMID:20628145 PMID:22460905 PMID:23257783 PMID:23292937 PMID:25355872 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26787899 PMID:27397505 PMID:28196595 PMID:29416618 PMID:29666304 PMID:30165192 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
CLO:CLO_0004265, EFO:EFO_0002200, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CRL-2260, BCRC:60486, BioSample:SAMN01821562, BioSample:SAMN01821633, BioSample:SAMN03472827, BioSample:SAMN03473482, BioSample:SAMN10987949, cancercelllines:CVCL_1290, Cell_Model_Passport:SIDM00661, ChEMBL-Cells:CHEMBL3308143, ChEMBL-Targets:CHEMBL2366130, Cosmic:687844, Cosmic:907063, Cosmic:1067441, Cosmic:1541915, Cosmic:1945181, Cosmic:2022501, Cosmic:2276317, Cosmic-CLP:907063, DepMap:ACH-000914, DSMZ:ACC-567, DSMZCellDive:ACC-567, EGA:EGAS00001000610, EGA:EGAS00001002554, GDSC:907063, GEO:GSM274841, GEO:GSM380127, GEO:GSM552431, GEO:GSM562824, GEO:GSM887143, GEO:GSM888215, GEO:GSM1035314, GEO:GSM1059806, GEO:GSM1151288, GEO:GSM1374558, GEO:GSM1669907, IARC_TP53:21377, IGRhCellID:HT, Kerafast:EMI025, LiGeA:CCLE_740, LINCS_LDP:LCL-1949, PharmacoDB:HT_624_2019, PRIDE:PXD030304, Progenetix:CVCL_1290, PubChem_Cell_line:CVCL_1290, Wikidata:Q54896490 |
|
|
CVCL_1290 |
2026-09-12 05:45:30 |
6 |